Bridge Pharmaceuticals, which helps pharma companies do drug research in China, raises $35M
Bridge Pharmaceuticals, a San Francisco company which lets pharmaceutical companies do pre-trial drug research in China, said it has raised $35 million in a third round of financing.
Granite Global Ventures led the round, which also included existing investors. Helen Wong, of Granite Global Ventures’ Shanghai office, has joined the board.
Earlier, Bridge raised at least $22 million from investors that included SRI International and WI Harper, among others.
Next Story: VC investments in China climb 55 percent in 2006, but slow in fourth quarter
Previous Story: Electronic Arts buys SingShot, the online social karaoke site
